Previous Article | Next Article ![]()
Journal of Virology, April 2001, p. 3547-3555, Vol. 75, No. 8
UCLA AIDS Institute and Department of
Microbiology and Immunology and Molecular Genetics and Department
of Medicine, Los Angeles, California 90095,1 and
Hematology Branch, National Heart, Lung, and Blood
Institute, Rockville, Maryland 208502
Received 16 August 2000/Accepted 16 January 2001
Nonhuman primate model systems of autologous CD34+ cell
transplant are the most effective means to assess the safety and
capabilities of lentivirus vectors. Toward this end, we tested the
efficiency of marking, gene expression, and transplant of bone marrow
and peripheral blood CD34+ cells using a self-inactivating
lentivirus vector (CS-Rh-MLV-E) bearing an internal murine leukemia
virus long terminal repeat derived from a murine retrovirus adapted to
replicate in rhesus macaques. In vitro cytokine stimulation was not
required to achieve efficient transduction of CD34+ cells
resulting in marking and gene expression of the reporter gene encoding
enhanced green fluorescent protein (EGFP) following transplant of the
CD34+ cells. Monkeys transplanted with mobilized peripheral
blood CD34+ cells resulted in EGFP expression in 1 to 10%
of multilineage peripheral blood cells, including red blood cells and
platelets, stable for 15 months to date. The relative level of gene
expression utilizing this vector is 2- to 10-fold greater than that
utilizing a non-self-inactivating lentivirus vector bearing the
cytomegalovirus immediate-early promoter. In contrast, in animals
transplanted with autologous bone marrow CD34+ cells,
multilineage EGFP expression was evident initially but diminished over
time. We further tested our lentivirus vector system by demonstrating
gene transfer of the human common gamma-chain cytokine receptor gene
(
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3547-3555.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Lentivirus Vector-Mediated Hematopoietic Stem Cell Gene Transfer
of Common Gamma-Chain Cytokine Receptor in Rhesus Macaques
c), deficient in X-linked SCID patients and recently
successfully used to treat disease. Marking was 0.42 and .001 HIV-1
vector DNA copy per 100 cells in two animals. To date, all EGFP- and
c-transplanted animals are healthy. This system may
prove useful for expression of therapeutic genes in human hematopoietic cells.
*
Corresponding author. Mailing address: UCLA School of
Medicine, 10833 LeConte Ave., 11-934 Factor Bldg., Los Angeles, CA
90095. Phone: (310) 825-4793. Fax: (310) 794-7682. E-mail:
rtaweesu{at}ucla.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|